Lataa...
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Imipenem-cilastatin was used to treat 79 febrile episodes in 71 cancer patients, most of whom had neutropenia. The overall response rate was 67%, and 76% of the 45 documented infections responded. The response rates for septicemias and pneumonias were 79 and 62%, respectively. Only 1 of the 17 infec...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1986
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180520/ https://ncbi.nlm.nih.gov/pubmed/3532942 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|